US FDA approves Vanda Pharmaceuticals’ Bysanti to treat bipolar I disorder and schizophrenia: Washington Monday, February 23, 2026, 12:00 Hrs [IST] Vanda Pharmaceuticals Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results